Cargando…

Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone

Prednisone, the prodrug of prednisolone, has been implicated as the cause of neuropsychiatric symptoms such as depression, mania, agitation, delirium, dementia, psychosis, and many other affective, behavioral, and cognitive changes. Although the literature suggests that patients on 40 mg or more of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesko, Aquila, Kalafat, Naciye, Afreen, Maleeha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801186/
https://www.ncbi.nlm.nih.gov/pubmed/35141097
http://dx.doi.org/10.7759/cureus.20853
_version_ 1784642398687592448
author Lesko, Aquila
Kalafat, Naciye
Afreen, Maleeha
author_facet Lesko, Aquila
Kalafat, Naciye
Afreen, Maleeha
author_sort Lesko, Aquila
collection PubMed
description Prednisone, the prodrug of prednisolone, has been implicated as the cause of neuropsychiatric symptoms such as depression, mania, agitation, delirium, dementia, psychosis, and many other affective, behavioral, and cognitive changes. Although the literature suggests that patients on 40 mg or more of prednisone a day are at a greater risk for steroid-induced psychosis, patients on <40 mg are still at risk, and therefore, steroid-induced psychosis should not be excluded from the differential. Prednisone is the prodrug of prednisolone, and the two are comparable on a milligram (mg)-to-mg basis. Here are four case studies, three from the literature and one new, that demonstrate acute psychosis secondary to low-dose prednisone/prednisolone use.
format Online
Article
Text
id pubmed-8801186
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-88011862022-02-08 Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone Lesko, Aquila Kalafat, Naciye Afreen, Maleeha Cureus Psychiatry Prednisone, the prodrug of prednisolone, has been implicated as the cause of neuropsychiatric symptoms such as depression, mania, agitation, delirium, dementia, psychosis, and many other affective, behavioral, and cognitive changes. Although the literature suggests that patients on 40 mg or more of prednisone a day are at a greater risk for steroid-induced psychosis, patients on <40 mg are still at risk, and therefore, steroid-induced psychosis should not be excluded from the differential. Prednisone is the prodrug of prednisolone, and the two are comparable on a milligram (mg)-to-mg basis. Here are four case studies, three from the literature and one new, that demonstrate acute psychosis secondary to low-dose prednisone/prednisolone use. Cureus 2021-12-31 /pmc/articles/PMC8801186/ /pubmed/35141097 http://dx.doi.org/10.7759/cureus.20853 Text en Copyright © 2021, Lesko et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Psychiatry
Lesko, Aquila
Kalafat, Naciye
Afreen, Maleeha
Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
title Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
title_full Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
title_fullStr Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
title_full_unstemmed Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
title_short Four Case Reports of Acute Psychosis Secondary to Low Doses of Prednisone/Prednisolone
title_sort four case reports of acute psychosis secondary to low doses of prednisone/prednisolone
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801186/
https://www.ncbi.nlm.nih.gov/pubmed/35141097
http://dx.doi.org/10.7759/cureus.20853
work_keys_str_mv AT leskoaquila fourcasereportsofacutepsychosissecondarytolowdosesofprednisoneprednisolone
AT kalafatnaciye fourcasereportsofacutepsychosissecondarytolowdosesofprednisoneprednisolone
AT afreenmaleeha fourcasereportsofacutepsychosissecondarytolowdosesofprednisoneprednisolone